J. Durant - Concepedia

Author

J. Durant

Also Known As

A De Monte, A Leplatois, C. Katlama, Christian Pradier, Durant, Jacques, E. Rosenthal, F. De Salvador, F. De Salvador-Guillouet, J DURANT, J Durant

160

Publications

3.8K

Citations

H-Index

112

Concepts

All Affiliations

Hôpital l'Archet Centre Hospitalier Universitaire de Nice Université Côte d'Azur Hôpital Pasteur Inserm

About

J. Durant is an author at Hôpital l'Archet specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	29	1.4K
2	Health Sciences	5	5	895
3	Public Health	3	3	40
4	Social Sciences	2	2	59
5	Cell Biology	1	1	19

J. Durant

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial J. Durant, Philippe Clevenbergh, Philippe Halfon, The Lancet Health SciencesTreatment And PreventionHuman RetrovirusPharmacologyClinical Trials	1999	761
Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study Antonella Castagna, Franco Maggiolo, Giovanni Penco, The Journal of Infectious Diseases	2014	322
Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study Joseph J. Eron, Bonaventura Clotet, J. Durant, The Journal of Infectious Diseases	2012	306
Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study J. Durant, Philippe Clevenbergh, R. Garraffo, AIDS	2000	223
Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era? Nelly Briand, Josiane Warszawski, Laurent Mandelbrot, Clinical Infectious Diseases	2013	126
Persisting Long-Term Benefit of Genotype-Guided Treatment for HIV-Infected Patients Failing Haart. The Viradapt Study: Week 48 Follow-Up Philippe Clevenbergh, J. Durant, Philippe Halfon, Antiviral Therapy	2000	114
PharmAdapt Philippe Clevenbergh, R. Garraffo, J. Durant, AIDS	2002	93
Immune changes in post-menopausal osteoporosis: the Immunos study Véronique Breuil, Michel Ticchioni, Jean Testa, Osteoporosis International Bone DiseaseBone HealthImmunologyMenopauseImmune Changes	2009	86
Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders? Matteo Vassallo, J. Durant, Virginie Biscay, AIDS	2013	64
COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated Karine Risso, Francine Guillouet-de-Salvador, Laure Valério, PLoS ONE	2017	50

Page 1